ArticleScientific reports2022
An automated cell line authentication method for AstraZeneca global cell bank using deep neural networks on brightfield images.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
- Genetic Insights into the Economic Toll of Cell Line Misidentification: A Comprehensive Review.Medical sciences (Basel, Switzerland) · 2026Review
- Authentication of RBK (Razi Bovine Kidney) Cell Line Derived from Primary Kidney Cell.Archives of Razi Institute · 2025Article
- Unlocking Potential: A Comprehensive Overview of Cell Culture Banks and Their Impact on Biomedical Research.Cells · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell line authentication is important in the biomedical field to ensure that researchers are not working with misidentified cells. Short tandem repeat is the gold standard method, but has its own limitations, including being expensive and time-consuming. Deep neural networks achieve great success in the analysis of cellular images in a cost-effective way. However, because of the lack of centralized available datasets, whether or not cell line authentication can be replaced or supported by cell image classification is still a question. Moreover, the relationship between the incubation times and cellular images has not been explored in previous studies. In this study, we automated the process of the cell line authentication by using deep learning analysis of brightfield cell line images. We proposed a novel multi-task framework to identify cell lines from cell images and predict the duration of how long cell lines have been incubated simultaneously. Using thirty cell lines' data from the AstraZeneca Cell Bank, we demonstrated that our proposed method can accurately identify cell lines from brightfield images with a 99.8% accuracy and predicts the incubation durations for cell images with the coefficient of determination score of 0.927. Considering that new cell lines are continually added to the AstraZeneca Cell Bank, we integrated the transfer learning technique with the proposed system to deal with data from new cell lines not included in the pre-trained model. Our method achieved excellent performance with a precision of 97.7% and recall of 95.8% in the detection of 14 new cell lines. These results demonstrated that our proposed framework can effectively identify cell lines using brightfield images.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.